688488 艾迪藥業
按盤價 
14.130 +0.280 (+2.022%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.576 | -13.407 | -6.545 | -9.893 | -2.246 |
| 總資產報酬率 ROA (%) | 0.828 | -7.810 | -4.472 | -8.032 | -2.081 |
| 投入資產回報率 ROIC (%) | 1.023 | -9.201 | -5.052 | -8.871 | -2.198 | 邊際利潤分析 |
| 銷售毛利率 (%) | 62.036 | 54.933 | 46.195 | 42.901 | 33.191 |
| 營業利潤率 (%) | 16.086 | -39.364 | -22.376 | -58.175 | -17.143 |
| 息稅前利潤/營業總收入 (%) | 17.740 | -36.632 | -19.843 | -58.139 | -17.375 |
| 淨利潤/營業總收入 (%) | 12.943 | -33.230 | -18.492 | -50.812 | -11.726 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 61.530 | 78.843 | 96.928 | 91.603 | 123.454 |
| 價值變動淨收益/利潤總額(%) | 28.634 | -10.678 | -15.376 | -11.805 | -19.142 |
| 營業外收支淨額/利潤總額(%) | -0.846 | 0.923 | 0.040 | 0.218 | -3.697 | 償債能力分析 |
| 流動比率 (X) | 1.405 | 1.379 | 1.775 | 2.419 | 8.936 |
| 速動比率 (X) | 0.992 | 0.986 | 1.399 | 1.949 | 7.701 |
| 資產負債率 (%) | 42.353 | 42.923 | 35.557 | 27.578 | 8.700 |
| 帶息債務/全部投入資本 (%) | 30.825 | 31.140 | 23.719 | 13.326 | -0.187 |
| 股東權益/帶息債務 (%) | 211.166 | 207.807 | 305.446 | 617.002 | -52,227.997 |
| 股東權益/負債合計 (%) | 124.135 | 122.234 | 181.238 | 262.608 | 1,049.375 |
| 利息保障倍數 (X) | 9.918 | -11.822 | -7.805 | -356.435 | 20.612 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 60.608 | 138.534 | 129.628 | 126.837 | 126.673 |
| 存貨周轉天數 (天) | 315.545 | 420.481 | 277.339 | 349.064 | 213.182 |
| 備註： | 即時報價更新時間為 03/06/2025 15:01 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
